# US 2012/0083426 A1 · Method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0083426 A1
- Document ID: US20120083426A1
- Status: Published application
- Kind: A1
- Application number: 13/188,031
- Filed: 2011-07-21
- Published: 2012-04-05
- Earliest claimed: 1999-11-24
- Inventors: Claus Lindvald JOHANSEN; Soren Kjaerulff; Susan Mampusta Madrid; Henrik Pedersen; Charlotte Horsmans Poulsen; Masoud Rajabi Zargahi
- Web page: https://patentgrep.com/patent/US20120083426A1

## CPC

- C07K 14/39: from yeasts
- C12N 15/81: for yeasts
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

A method is described for releasing a soluble or membrane associated intracellular protein of interest (POI) comprising the steps of: providing a cell comprising a soluble or membrane associated intracellular POI; contacting the cell with a membrane extracting composition; and causing the POI to be released from the cell under conditions sufficient for the specific release of the POI and in a soluble form.

## Claims

### Claim 1

A method for extracting a soluble or membrane associated intracellular recombinant protein of interest (POI) from a bacterial, yeast or fungal cell comprising the steps of:
(a) providing a bacterial, yeast or fungal cell comprising a soluble or membrane associated intracellular recombinant POI;
(b) releasing the recombinant POI from the cell by contacting the cell with a membrane extracting composition comprising a quarternary ammonium compound at a concentration of between 0.05% to 0.6% by weight, under conditions sufficient for the release of the recombinant POI and in a soluble form
(c) recovering the recombinant POI from the membrane extracting composition.

### Claim 2 (depends on 1)

A method according to claim 1 in which the bacterial, yeast or fungal cell is a transformed cell.

### Claim 3 (depends on 1)

A method according to claim 1 in which the intracellular recombinant POI is produced by recombinant DNA techniques.

### Claim 4 (depends on 1)

A method according to claim 1, in which the cell is a yeast cell.

### Claim 5 (depends on 1)

A method according to claim 1, in which the quarternary ammonium compound is selected from the group consisting of Lauroyl Trimethyl Ammonium Bromide (LTAB), Myristyl Trimethyl Ammonium Chloride (MTAC), CetylTrimethyl Ammonium Chloride (CTAC), Cetrimide, Cetyl Trimethyl Ammonium Bromide (CTAB), Stearoyl Trimethyl Ammonium Chloride (STAC), Stearoyl Trimethyl Ammonium Bromide (STAB), Benzalkonium Chloride (alkyldimethylbenzylammonium chloride), N-Cetylpyridinium Bromide (N-Hexadecylpyridinium bromide), N-Cetylpyridinium Chloride (N-Hexadecylpyridinium chloride), Benzyl Dimethyl Tetradecyl Ammonium Chloride, Benzyl Dimethyl Hexadecyl Ammonium Chloride and a combination of any two or more thereof.

### Claim 6 (depends on 1)

A method according to claim 1 in which the bacterial yeast or fungal cell is contacted with the membrane extracting composition at temperatures from 4° C. to 40° C.

### Claim 7 (depends on 1)

A method according to claim 1 in which the bacterial, yeast or fungal cell is contacted with the membrane extracting composition at a pH of from 2.0 to 11.0.

### Claim 8 (depends on 1)

A method for screening for mutated cells or transformed cells producing elevated levels of a soluble or membrane associated intracellular recombinant POI comprising the steps of:
(a) growing the mutated cells at 30° C.;
(b) incubating the mutated cells or transformed cells with the membrane extracting composition in a method as defined in claim 1,
(c) recovering the cell free medium;
(d) screening the cell free medium for elevated levels of the intracellular recombinant POI;
such that the presence of the intracellular recombinant POI in the cell free medium is indicative that the intracellular recombinant POI has been released, in which the mutated or transformed cell is a bacterial, yeast or fungal cell.

### Claim 9

A method of using a membrane extracting composition comprising a quaternary ammonium compound to extract a soluble or membrane associated intracellular recombinant POI from a bacterial, yeast or fungal cell, in which the membrane extracting composition comprises a quaternary ammonium compound at a concentration of between 0.05% to 0.6% by weight and is contacted with the bacterial, yeast or fungal cell, and in which the released recombinant POI is recovered from the membrane extracting composition.

### Claim 10

A method for screening for mutated cells or transformed cells producing elevated levels of a soluble or membrane associated intracellular recombinant POI comprising the steps of:
(a) growing the mutated cells at 30° C.;
(b) incubating the mutated cells or transformed cells with the membrane extracting composition comprising a quaternary ammonium compound at a concentration of between 0.05% to 0.6% by weight;
(c) recovering the cell free medium
(d) screening the cell free medium for elevated levels of the intracellular recombinant POI;
such that the presence of the intracellular recombinant POI in the cell free medium is indicative that the intracellular recombinant POI has been released.

### Claim 11

A membrane extracting composition suitable for releasing a soluble or membrane associated intracellular recombinant POI, wherein the composition is contacted with the cell under the following conditions:
(a) a percentage by weight of quaternary ammonium compound from about 0.05% to about 0.6%;
(b) a pH of from about 2.0 to about 11.0
(c) a temperature of from about 4° C. to about 40° C.;
Such that the intracellular recombinant POI substantially free of contaminating proteins is obtained.

### Claim 12

A method of using a membrane extracting composition comprising a quaternary ammonium compound to extract a soluble or membrane associated intracellular recombinant POI from a bacterial, yeast or fungal cell, the POI being released from the bacterial, yeast or fungal cell, in which the membrane extracting composition comprises a quaternary ammonium compound at a concentration of between 0.05% to 0.6% by weight and is contacted with the bacterial, yeast or fungal cell and in which the released recombinant POI is recovered from the membrane extracting composition.

### Claim 13 (depends on 1)

The method according to claim 1, in which the recombinant POI is a glucan lyase.

### Claim 14 (depends on 9)

The method according to claim 9, in which the recombinant POI is a glucan lyase.

### Claim 15 (depends on 10)

The method according to claim 10, in which the recombinant POI is a glucan lyase.

### Claim 16 (depends on 12)

The method according to claim 12, in which the recombinant POI is a glucan lyase.

### Claim 17 (depends on 1)

The method according to claim 1, in which the recombinant POI is an interleukin-1 receptor antagonist (IL-1ra).

### Claim 18 (depends on 9)

The method according to claim 9, in which the recombinant POI is an interleukin-1 receptor antagonist (IL-1ra).

### Claim 19 (depends on 10)

The method according to claim 10, in which the recombinant POI is an interleukin-1 receptor antagonist (IL-1ra).

### Claim 20 (depends on 12)

The method according to claim 12, in which the recombinant POI is an interleukin-1 receptor antagonist (IL-1ra).

### Claim 21 (depends on 1)

The method according to claim 1, in which the recombinant POI is hexose oxidase (HOX) enzyme.

### Claim 22 (depends on 9)

The method according to claim 9, in which the recombinant POI is hexose oxidase (HOX) enzyme.

### Claim 23 (depends on 10)

The method according to claim 10, in which the recombinant POI is hexose oxidase (HOX) enzyme.

### Claim 24 (depends on 12)

The method according to claim 12, in which the recombinant POI is hexose oxidase (HOX) enzyme.

### Claim 25 (depends on 21)

The method according to claim 21, in which the hexose oxidase (HOX) enzyme comprises the amino acid sequence set out in SEQ ID No 22.

### Claim 26 (depends on 22)

The method according to claim 22, in which the hexose oxidase (HOX) enzyme comprises the amino acid sequence set out in SEQ ID No 22.

### Claim 27 (depends on 23)

The method according to claim 23, in which the hexose oxidase (HOX) enzyme comprises the amino acid sequence set out in SEQ ID No 22.

### Claim 28 (depends on 24)

The method according to claim 24, in which the hexose oxidase (HOX) enzyme comprises the amino acid sequence set out in SEQ ID No 22.

### Claim 29 (depends on 21)

The method according to claim 21, in which the hexose oxidase (HOX) enzyme is encoded by a nucleotide sequence set out in SEQ ID No 22.

### Claim 30 (depends on 22)

The method according to claim 22, in which the hexose oxidase (HOX) enzyme is encoded by a nucleotide sequence set out in SEQ ID No 22.

### Claim 31 (depends on 23)

The method according to claim 23, in which the hexose oxidase (HOX) enzyme is encoded by a nucleotide sequence set out in SEQ ID No 22.

### Claim 32 (depends on 24)

The method according to claim 24, in which the hexose oxidase (HOX) enzyme is encoded by a nucleotide sequence set out in SEQ ID No 22.

### Claim 33 (depends on 21)

The method according to claim 21, in which the hexose oxidase (HOX) enzyme is encoded by a nucleotide sequence capable of hybridising to the nucleotide sequence set out in SEQ ID No 22.

### Claim 34 (depends on 22)

The method according to claim 22, in which the hexose oxidase (HOX) enzyme is encoded by a nucleotide sequence capable of hybridising to the nucleotide sequence set out in SEQ ID No 22.

### Claim 35 (depends on 23)

The method according to claim 23, in which the hexose oxidase (HOX) enzyme is encoded by a nucleotide sequence capable of hybridising to the nucleotide sequence set out in SEQ ID No 22.

### Claim 36 (depends on 24)

The method according to claim 24, in which the hexose oxidase (HOX) enzyme is encoded by a nucleotide sequence capable of hybridising to the nucleotide sequence set out in SEQ ID No 22.

### Claim 37 (depends on 1)

A POI producible by a method according to claim 1 wherein said POI is glucan lyase.

### Claim 38 (depends on 1)

A POI producible by a method according to claim 1 wherein said POI is interleukin-1 receptor antagonist.

### Claim 39 (depends on 1)

A POI producible by a method according to claim 1 wherein said POI is hexose oxidase (HOX).

### Claim 40 (depends on 1)

A POI producible by the method according to claim 1 wherein said POI is hexose oxidase enzyme and said HOX enzyme is encoded by a nucleotide sequence, and wherein the nucleotide sequence set out in SEQ ID NO: 22, or a sequence complementary to the hybridisable sequence, and wherein the nucleotide sequence is synthesised by the oligonucleotides as set out in SEQ ID NOs: 2-22.

### Claim 41 (depends on 1)

A POI as defined in claim 1, wherein the POI is released in a substantially non-glycosylated form from a eukaryotic host organism.

### Claim 42

A substantially non-glycosylated POI released from a eukaryotic host organism.

### Claim 43 (depends on 1)

A substantially non-glycosylated POI released from a eukaryotic host organism, wherein the POI is released by the method of claim 1.
